Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by Phytochemicals
Open Access
- 1 January 2009
- journal article
- research article
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2009, 1-9
- https://doi.org/10.1155/2009/491985
Abstract
CXCR4 is a chemokine receptor frequently overexpressed on primary tumor cells. Organs to which these cancers metastasize secrete CXCL12, the unique ligand for CXCR4, which stimulates invasion and metastasis to these sites. Similar to our previous work with the chemoprotective phytochemical, 3,-diindolylmethane (DIM), we show here that genistein also downregulates CXCR4 and CXCL12 and subsequently lowers the migratory and invasive potentials of breast and ovarian cancer cells. Moreover, genistein and DIM elicit a significantly greater cumulative effect in lowering CXCR4 and CXCL12 levels than either compound alone. Our data suggest a novel mechanism for the protective effects of phytochemicals against cancer progression and indicate that in combination, these compounds may prove even more efficacious.Keywords
Funding Information
- American Institute for Cancer Research (441450-58819-OH)
This publication has 30 references indexed in Scilit:
- CXCR4 and CXCL12 down-regulation: A novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancersCancer Letters, 2008
- A Proposed Mechanism for the Protective Effect of Dioxin against Breast CancerToxicological Sciences, 2007
- Potentiation of the Effect of Erlotinib by Genistein in Pancreatic Cancer: The Role of Akt and Nuclear Factor-κBCancer Research, 2006
- One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal womenEuropean Journal of Clinical Nutrition, 2006
- Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1α (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-κB ActivationCancer Research, 2005
- Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementationThe Prostate, 2005
- Inactivation of Nuclear Factor κB by Soy Isoflavone Genistein Contributes to Increased Apoptosis Induced by Chemotherapeutic Agents in Human Cancer CellsCancer Research, 2005
- PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEDrug Metabolism and Disposition, 2004
- Genistein: does it prevent or promote breast cancer?Environmental Health Perspectives, 2000
- Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethaneCarcinogenesis: Integrative Cancer Research, 1998